Sai Life Sciences Ltd Allots 170,501 Shares Through Employee Stock Option Plans
Sai Life Sciences Ltd has announced the allotment of fully paid-up equity shares totaling 1,70,501 upon the exercise of options granted under its Employees Stock Option Plan 2008 (ESOP 2008) and the Management ESOP Plan 2018 (MESOP 2018).The Board of Directors approved the allotment on June 22, 2026. The shares issued under these schemes were fully paid at a par value of Rs. 1/- per share.
The allotment details are as follows:
- Shares allotted under ESOP 2008: 5,002
- Shares allotted under MESOP 2018: 1,65,499
- Total shares issued: 1,70,501
The company realized INR 1,88,41,004.50 from the exercise of these options.
Scheme Details and Financial Metrics
The issuance details highlight different pricing structures across the two schemes. For ESOP 2008, the exercise price was Rs. 188.90/- per share, resulting in a premium of Rs. 187.90/- per share.Details regarding the allotment and financial specifics are summarized below:
| Scheme | Shares Allotted | Exercise Price Per Share | Premium Per Share |
|---|---|---|---|
| ESOP 2008 | 5,002 | Rs. 188.90/- | Rs. 187.90/- |
| MESOP 2018 (Option Set A) | 30,499* | Rs. 23.30/- | Rs. 22.30/- |
| MESOP 2018 (Option Set B) | 1,35,000* | Rs. 127.30/- | Rs. 126.30/- |
Note: The allotment encompasses options from both ESOP 2008 and MESOP 2018 for a combined total of 1,70,501 shares.
Post-Issue Share Capital Status
Following the issuance of these shares, Sai Life Sciences Ltd reported that the total issued shares stand at 21,22,86,016. The total issued share capital has consequently reached 21,22,86,016.The objective of both ESOP 2008 and MESOP 2018 is to attract, retain, and reward employees, thereby contributing to the company’s growth. These plans have a maximum vesting period of five years, with various options for vesting as defined in the scheme documents.
SAILIFE Stock Price Movement
Sai Life Sciences Limited shares today slipped by 0.95% to settle at ₹1216.4, closing after a day of declining momentum. The stock traded on a volume of 499,268 shares in the post-market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.